AI Precision for Melanoma Care
Stratify, predict, and act on melanoma risk with clinical-grade AI.
We fuse histopathology, genomics, and clinical signals to deliver patient-level stratification, early risk alerts, and therapy insights—so teams can intervene sooner and personalize care.
Live Cohort Overview
StableHigh-risk patients
14%
vs 22% baselineInsight
Early stratification reduced time-to-intervention by 18 days.
Platform
Built for oncology teams, validated for melanoma.
An integrated stack that delivers transparent, actionable outputs clinicians trust.
Multimodal AI engine
Combines whole-slide imaging, genomics, and clinical data to produce patient-level stratification scores.
Explainable outputs
Heatmaps and feature attributions make each prediction auditable and clinician friendly.
Secure delivery
Deployed in HIPAA-ready cloud or on-prem, with audit trails and role-based access built in.
Science
Stratification that meets clinical rigor.
Co-developed with melanoma specialists and benchmarked against leading academic datasets.
AUROC
0.94
Across stage I-III melanoma cohorts.
Time saved
18 days
Median reduction in time-to-intervention for high-risk patients.
Coverage
250k+
Whole-slide images and paired clinical records validated.
Explainability
100%
Heatmaps and feature attributions for every prediction.
Workflow
From slide to stratification in minutes.
Fits into existing pathology and oncology workflows, no rip-and-replace.
Ingest
Upload WSIs, genomics, and clinical data via secure connectors or PACS.
Analyze
Models segment, grade, and stratify with uncertainty estimates and QA checks.
Explain
Clinicians review heatmaps, feature attributions, and confidence metrics.
Act
Push alerts to tumor boards, EMR, and care coordination tools.
Get a live demo
See how OncoStrata AI supports your melanoma program.
Share your current workflow and we will tailor a pilot in under two weeks.